date:Dec 18, 2013
Danish food ingredients maker Chr. Hansen is in discussions with companies over using probiotic bacteria to reduce the risk of a deadly stomach disease among premature babies.
An independent study by the Royal Women's Hospital in Melbourne has shown that daily intake of a mix of three of Chr. Hansen's probiotic strains more than halved the risk among premature babies of developing necrotizing enterocolitis (NEC) compared with infants that received a placebo.
The study was conducted on 1,100 ch